PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers

Akira Yokomizo, Donald J. Tindall, Harry Drabkin, Robert Gemmill, Wilbur Franklin, Ping Yang, Kenji Sugio, David I. Smith, Wanguo Liu

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

A putative tumor suppressor, PTEN/MMAC1 gene at 10q23 was recently identified and found to be mutated in many different human tumors. To determine the role of the PTEN/MMAC1 gene in lung cancer, we screened 34 small cell lung cancer (SCLC) cell lines, 10 SCLC tumors, 13 non-small cell lung cancer (NSCLC) cell lines and 10 NSCLC tumors using Denaturing HPLC (DHPLC) and direct sequencing methods. In SCLC, six (18%) of the cell lines and one of the primary tumor samples (10%) showed alterations of the PTEN/MMAC1 gene including point mutations, small fragment deletions, and homozygous deletions. All of the point mutations and small fragment deletions were observed in hemizygously deleted cell lines. In contrast to SCLC, none of the NSCLC tumors or cell lines had mutations in the PTEN/MMAC1 gene. These data indicate that PTEN/MMAC1 mutations contribute to the pathogenesis and neoplastic evolution in SCLC but not in NSCLC.

Original languageEnglish
Pages (from-to)475-479
Number of pages5
JournalOncogene
Volume17
Issue number4
DOIs
Publication statusPublished - Jul 30 1998

Fingerprint

Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
Mutation
Cell Line
Neoplasms
Point Mutation
Genes
Tumor Cell Line
Lung Neoplasms
High Pressure Liquid Chromatography

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Yokomizo, A., Tindall, D. J., Drabkin, H., Gemmill, R., Franklin, W., Yang, P., ... Liu, W. (1998). PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene, 17(4), 475-479. https://doi.org/10.1038/sj.onc.1201956

PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. / Yokomizo, Akira; Tindall, Donald J.; Drabkin, Harry; Gemmill, Robert; Franklin, Wilbur; Yang, Ping; Sugio, Kenji; Smith, David I.; Liu, Wanguo.

In: Oncogene, Vol. 17, No. 4, 30.07.1998, p. 475-479.

Research output: Contribution to journalArticle

Yokomizo, A, Tindall, DJ, Drabkin, H, Gemmill, R, Franklin, W, Yang, P, Sugio, K, Smith, DI & Liu, W 1998, 'PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers', Oncogene, vol. 17, no. 4, pp. 475-479. https://doi.org/10.1038/sj.onc.1201956
Yokomizo A, Tindall DJ, Drabkin H, Gemmill R, Franklin W, Yang P et al. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene. 1998 Jul 30;17(4):475-479. https://doi.org/10.1038/sj.onc.1201956
Yokomizo, Akira ; Tindall, Donald J. ; Drabkin, Harry ; Gemmill, Robert ; Franklin, Wilbur ; Yang, Ping ; Sugio, Kenji ; Smith, David I. ; Liu, Wanguo. / PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. In: Oncogene. 1998 ; Vol. 17, No. 4. pp. 475-479.
@article{99ca5721e2c046fbbc435a51b189e3b1,
title = "PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers",
abstract = "A putative tumor suppressor, PTEN/MMAC1 gene at 10q23 was recently identified and found to be mutated in many different human tumors. To determine the role of the PTEN/MMAC1 gene in lung cancer, we screened 34 small cell lung cancer (SCLC) cell lines, 10 SCLC tumors, 13 non-small cell lung cancer (NSCLC) cell lines and 10 NSCLC tumors using Denaturing HPLC (DHPLC) and direct sequencing methods. In SCLC, six (18{\%}) of the cell lines and one of the primary tumor samples (10{\%}) showed alterations of the PTEN/MMAC1 gene including point mutations, small fragment deletions, and homozygous deletions. All of the point mutations and small fragment deletions were observed in hemizygously deleted cell lines. In contrast to SCLC, none of the NSCLC tumors or cell lines had mutations in the PTEN/MMAC1 gene. These data indicate that PTEN/MMAC1 mutations contribute to the pathogenesis and neoplastic evolution in SCLC but not in NSCLC.",
author = "Akira Yokomizo and Tindall, {Donald J.} and Harry Drabkin and Robert Gemmill and Wilbur Franklin and Ping Yang and Kenji Sugio and Smith, {David I.} and Wanguo Liu",
year = "1998",
month = "7",
day = "30",
doi = "10.1038/sj.onc.1201956",
language = "English",
volume = "17",
pages = "475--479",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers

AU - Yokomizo, Akira

AU - Tindall, Donald J.

AU - Drabkin, Harry

AU - Gemmill, Robert

AU - Franklin, Wilbur

AU - Yang, Ping

AU - Sugio, Kenji

AU - Smith, David I.

AU - Liu, Wanguo

PY - 1998/7/30

Y1 - 1998/7/30

N2 - A putative tumor suppressor, PTEN/MMAC1 gene at 10q23 was recently identified and found to be mutated in many different human tumors. To determine the role of the PTEN/MMAC1 gene in lung cancer, we screened 34 small cell lung cancer (SCLC) cell lines, 10 SCLC tumors, 13 non-small cell lung cancer (NSCLC) cell lines and 10 NSCLC tumors using Denaturing HPLC (DHPLC) and direct sequencing methods. In SCLC, six (18%) of the cell lines and one of the primary tumor samples (10%) showed alterations of the PTEN/MMAC1 gene including point mutations, small fragment deletions, and homozygous deletions. All of the point mutations and small fragment deletions were observed in hemizygously deleted cell lines. In contrast to SCLC, none of the NSCLC tumors or cell lines had mutations in the PTEN/MMAC1 gene. These data indicate that PTEN/MMAC1 mutations contribute to the pathogenesis and neoplastic evolution in SCLC but not in NSCLC.

AB - A putative tumor suppressor, PTEN/MMAC1 gene at 10q23 was recently identified and found to be mutated in many different human tumors. To determine the role of the PTEN/MMAC1 gene in lung cancer, we screened 34 small cell lung cancer (SCLC) cell lines, 10 SCLC tumors, 13 non-small cell lung cancer (NSCLC) cell lines and 10 NSCLC tumors using Denaturing HPLC (DHPLC) and direct sequencing methods. In SCLC, six (18%) of the cell lines and one of the primary tumor samples (10%) showed alterations of the PTEN/MMAC1 gene including point mutations, small fragment deletions, and homozygous deletions. All of the point mutations and small fragment deletions were observed in hemizygously deleted cell lines. In contrast to SCLC, none of the NSCLC tumors or cell lines had mutations in the PTEN/MMAC1 gene. These data indicate that PTEN/MMAC1 mutations contribute to the pathogenesis and neoplastic evolution in SCLC but not in NSCLC.

UR - http://www.scopus.com/inward/record.url?scp=0032581519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032581519&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1201956

DO - 10.1038/sj.onc.1201956

M3 - Article

VL - 17

SP - 475

EP - 479

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 4

ER -